Detalles de la búsqueda
1.
Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size.
Cardiology
; 146(6): 705-712, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34343998
2.
SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.
Scand Cardiovasc J
; 54(6): 339-345, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32400206
3.
Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.
N Engl J Med
; 374(22): 2131-41, 2016 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27192541
4.
Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents.
Scand Cardiovasc J
; 48(3): 148-55, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24548278
5.
A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease.
Am Heart J
; 162(4): 740-7, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21982668
6.
Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial.
J Interv Cardiol
; 24(2): 105-11, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21175845
7.
Intracoronary compared to intravenous abciximab in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention reduces mortality, target vessel revascularization and reinfarction after 1 year.
Cardiology
; 120(1): 43-9, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22122887
8.
Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
Eur Heart J
; 29(22): 2733-41, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18832385
9.
Intravascular ultrasound assessment of expansion of the sirolimus-eluting (cypher select) and paclitaxel-eluting (Taxus Express-2) stent in patients with diabetes mellitus.
Am J Cardiol
; 102(1): 19-26, 2008 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18572030
10.
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.
JAMA
; 299(4): 409-16, 2008 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-18230778
11.
Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments.
EuroIntervention
; 14(7): 764-771, 2018 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29969425
12.
Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study.
Circulation
; 114(18): 1955-61, 2006 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-17060387
13.
10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents.
J Am Coll Cardiol
; 69(6): 616-624, 2017 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28183505
14.
Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study.
PLoS One
; 9(11): e113399, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25409336
15.
Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
JACC Cardiovasc Interv
; 6(11): 1160-5, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24262616
16.
Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results.
J Am Coll Cardiol
; 62(1): 30-4, 2013 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23644088
17.
Impact of abciximab in diabetic patients with acute coronary syndrome who undergo percutaneous coronary intervention: results from a high-volume, single-center registry.
J Invasive Cardiol
; 23(1): 21-6, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21183766
18.
Long-term clinical outcome in STEMI patients treated with primary PCI and drug-eluting or bare-metal stents: insights from a high-volume single-center registry.
J Invasive Cardiol
; 23(8): 328-33, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21828395
19.
Anthracycline-induced cardiomyopathy: favourable effects of cardiac resynchronization therapy.
Int J Cardiol
; 142(2): e23-4, 2010 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-19135740
20.
Serial intravascular ultrasound analysis of peri-stent remodeling and proximal and distal edge effects after sirolimus-eluting or paclitaxel-eluting stent implantation in patients with diabetes mellitus.
Am J Cardiol
; 103(8): 1083-8, 2009 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19361594